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Findings reported by Yi-Yun Liu and 
colleagues1 identified the plasmid-
borne gene mcr-1 encoding resistance 
to colistin with a high prevalence in 
Escherichia coli isolates from animals, 
foodstuﬀ , and human beings in China. 
The same gene was then reported in 
Europe (Denmark) among extended-
spectrum β lactamase (ESBL) and 
AmpC-producing E coli isolates from 
chicken meat and human infections, 
but at a very low prevalence.2
We screened ESBL-positive E coli 
isolates collected in France for colistin 
resistance. Isolates were collected 
between 2005 and mid-2014 from 
faeces of diarrhoeic veal calves at farms, 
as part of a survey in the context of 
the French antimicrobial resistance 
Resapath surveillance network for 
animal pathogens. We screened these 
isolates for colistin resistance using 
disk diﬀ usion and minimum inhibitory 
concentration determination by broth 
microdilution. We analysed plasmids 
bearing the mcr-1 gene by conjugation, 
S1-pulsed-ﬁ eld gel electrophoresis, PCR-
based replicon typing, and Southern 
blot. We analysed clonal relationship of 
all isolates by enterobacterial repetitive 
intergenic consensus PCR and pulsed-
ﬁ eld gel electrophoresis. 
Of 517 ESBL-producing E coli isolates 
collected, 106 (21%) were mcr-1 
positive. Notably, the oldest mcr-1-
positive E coli isolate had been collected 
in 2005. The 106 mcr-1-positive 
E coli isolates originated from diﬀ erent 
individuals located in 94 widely distant 
farms, and they were clonally unrelated.
Sequencing of the whole mcr-1 gene 
in 75 mcr-1-positive isolates revealed 
a 100% identity compared with the 
original sequence. Co-occurrence 
of the mcr-1 and ESBL genes was 
identiﬁ ed in a subset of seven isolates, 
with mcr-1 and blaCTX-M-1 being found 
on a large and conjugative IncHI2-
type plasmid together with genes 
conferring resistance to sulfonamides 
and tetracyclines, two antibiotics 
widely used in veterinary medicine.
These findings demonstrate a 
colocation of the mcr-1 gene along 
with an ESBL gene on a single plasmid, 
and additional studies are needed 
to clarify the diversity of the plasmid 
backbones spreading these two genes 
within our collection. Noticeably, 
the prevalence of the mcr-1 gene 
among ESBL producers in veal calves 
was much higher than that found in 
ESBL-positive E coli isolates in human 
beings and chicken meat reported in 
Denmark.2 This diﬀ erence may reﬂ ect 
a major spread of the mcr-1 gene in 
European live animals. We showed 
that the dissemination of mcr-1, at 
least in France, had already occurred 
more than a decade ago, with one E coli 
isolate collected in 2005 identiﬁ ed as 
mcr-1 positive.
Altogether, available data reveal 
the occurrence of mcr-1 among 
diﬀ erent animals and human contexts 
over time.1–3 Worryingly, we show 
that selection pressure with broad-
spectrum cephalosporins may select 
for colistin resistance and vice-versa, 
further highlighting the likelihood of 
a pandemic spread of mcr-1. Of note, 
the substantial use of tetracyclines 
and sulfonamides in animals might 
also substantially contribute to the 
dissemination of mcr-1 plasmids.
In a one-health perspective, and 
considering the renewed importance 
of colistin in human medicine, 
our data and those from others 
underscore the urgent need to limit 
the spread of mcr-1-positive plasmids 
by reconsidering the massive use 
of colistin in veterinary medicine 
worldwide.
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